Wells Fargo & Company Wave Life Sciences Ltd. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 26,079 shares of WVE stock, worth $169,774. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,079
Previous 18,259
42.83%
Holding current value
$169,774
Previous $92,000
73.91%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding WVE
# of Institutions
139Shares Held
72.3MCall Options Held
86.1KPut Options Held
20.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.69MShares$50 Million0.94% of portfolio
-
M28 Capital Management LP Stamford, CT7MShares$45.6 Million40.53% of portfolio
-
Black Rock Inc. New York, NY6.38MShares$41.5 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY5.35MShares$34.8 Million2.81% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.2MShares$33.9 Million0.06% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $565M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...